USO 19225

Trial Information

A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety and Efficacy Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castrate Resistant Prostate Cancer

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Prostate Cancer

Locations

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology